Virological failure and HIV drug resistance among adults living with HIV on second‐line antiretroviral therapy in the Asia‐Pacific-Reference-Cited by-同舟云学术

Virological failure and HIV drug resistance among adults living with HIV on second‐line antiretroviral therapy in the Asia‐Pacific

Published:2020-11-05 Issue:3 Volume:22 Page:201-211
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Ross J¹^ORCID,Jiamsakul A²^ORCID,Kumarasamy N³,Azwa I⁴,Merati TP⁵,Do CD⁶,Lee MP⁷,Ly PS⁸,Yunihastuti E⁹,Nguyen KV¹⁰,Ditangco R¹¹,Ng OT¹²,Choi JY¹³^ORCID,Oka S¹⁴,Sohn AH¹,Law M²

Affiliation:

1. TREAT Asia/amfAR –The Foundation for AIDS Research Bangkok Thailand

2. The Kirby Institute UNSW Sydney Kensington NSW Australia

3. Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS) VHS‐Infectious Diseases Medical Centre VHS Chennai India

4. Infectious Diseases Unit Department of Medicine Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

5. Faculty of Medicine Udayana University & Sanglah Hospital Bali Indonesia

6. Bach Mai Hospital Hanoi Vietnam

7. Queen Elizabeth Hospital Hong Kong SAR Hong Kong

8. National Center for HIV/AIDS Dermatology & STDs Phnom Penh Cambodia

9. Faculty of Medicine Universitas Indonesia ‐ Dr Cipto Mangunkusumo General Hospital Jakarta Indonesia

10. National Hospital for Tropical Diseases Hanoi Vietnam

11. Research Institute for Tropical Medicine Muntinlupa City Philippines

12. Tan Tock Seng Hospital Singapore Singapore

13. Division of Infectious Diseases Department of Internal Medicine Yonsei University College of Medicine Seoul South Korea

14. National Center for Global Health and Medicine Tokyo Japan

Funder

National Institutes of Health

ViiV Healthcare

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13006

Reference48 articles.

1. UNAIDS.2018 Global HIV Statistics Fact Sheet.2019.

2. Profile of HIV patients on second line antiretroviral therapy: the indian experience;Patrikar S;J AIDS Clin Res,2015

3. Durability of antiretroviral therapy regimens and determinants for change in HIV‐1‐infected patients in the TREAT Asia HIV Observational Database (TAHOD‐LITE);Martinez‐Vega R;Antivir Ther,2018

4. WHO.Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Second edition.2016.

5. WHO.Update of recommendations on first‐ and second‐line antiretroviral regimens. Policy Brief.2019.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults;BMC Infectious Diseases;2024-03-28

2. HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon;BMC Infectious Diseases;2024-03-14

3. Mortality Risk Factors Among People Living with HIV Receiving Second-line Antiretroviral Therapy in Rural China;Current HIV Research;2024-03

4. HIV Drug Resistance Mutations and Subtype Profiles among Pregnant Women of Ho Chi Minh City, South Vietnam;Viruses;2023-09-27

5. Determinants of virological failure in HIV1 infected patients followed in a third-level hospital Abidjan, Cote d’Ivoire;Indian Journal of Microbiology Research;2023-07-15